LD-2 disclosure · 3rd Quarter - Report
WOMEN'S INTERNATIONAL PHARMACY
Client
- Description
- Retail pharmacy.
- Location
- Wisconsin · United States of America
Registrant
- Description
- Government relations consultant.
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
3 issuesHealth Issues
H.R.1959, Preserving Patient Access to Compounded Medications Act of 2019. Also, FDA action on the Memorandum of Understanding (MOU) for human compounded medications. Also, potential FDA guidance on compounding from bulk ingredients for animal drug compounding.
LobbyistsJAMES W ROCK
TargetedSENATE · HOUSE OF REPRESENTATIVES · Food & Drug Administration (FDA)
Budget/Appropriations
H.R.1959, Preserving Patient Access to Compounded Medications Act of 2019. Also, FDA action on the Memorandum of Understanding (MOU) for human compounded medications. Also, potential FDA guidance on compounding from bulk ingredients for animal drug compounding.
LobbyistsJAMES W ROCK
TargetedSENATE · HOUSE OF REPRESENTATIVES · Food & Drug Administration (FDA)
Pharmacy
H.R.1959, Preserving Patient Access to Compounded Medications Act of 2019. Also, FDA action on the Memorandum of Understanding (MOU) for human compounded medications. Also, potential FDA guidance on compounding from bulk ingredients for animal drug compounding.
LobbyistsJAMES W ROCK